Latest News

Shanghai Industrial Urban Development Group (SEHK:563) has reported FY 2025 first half revenue of HK$1,827.8 million, with a basic EPS loss of HK$0.10. This puts the focus firmly on how efficiently that top line is translating into bottom line results. Over the past year of reported periods, revenue has ranged from HK$2,980.8 million in 1H 2024 to HK$9,459.5 million in 2H 2024. Over the same intervals, basic EPS has moved between a loss of HK$0.02 and a loss of HK$0.10, giving investors a...

Over the last 7 days, the United States market has dropped 2.3%, yet it remains up by 13% over the past year with earnings forecasted to grow by 16% annually. In this context of fluctuating performance, identifying small-cap stocks with potential insider buying can be an intriguing strategy for investors seeking opportunities that may not be immediately apparent in larger market trends.

Kunlun Energy FY 2025 earnings snapshot Kunlun Energy (SEHK:135) has reported fresh numbers for FY 2025, with first half revenue of C¥97.5b and basic EPS of C¥0.37. The company’s revenue moved from C¥94.1b and EPS of C¥0.31 in 2H 2024 to C¥97.5b and C¥0.37 in 1H 2025. Trailing twelve month EPS is C¥0.62 on revenue of C¥195.8b, leaving investors weighing a modest earnings profile against margins that remain relatively thin. See our full analysis for Kunlun Energy. With the headline figures...

Over the last 7 days, the United States market has experienced a 2.3% drop, yet it remains up by 13% over the past year with earnings projected to grow by 16% annually. In this context, identifying stocks that are trading below their intrinsic value can present opportunities for investors seeking to capitalize on potential long-term gains amidst fluctuating market conditions.

The recent 13% drop in Indaptus Therapeutics, Inc.'s ( NASDAQ:INDP ) stock could come as a blow to insiders who...

Fresh off its FY 2025 results, Xiaomi (SEHK:1810) reported fourth quarter revenue of about CN¥116.9b and basic EPS of CN¥0.25, setting the tone for a year where trailing 12 month revenue reached roughly CN¥457.3b and basic EPS came in at CN¥1.62. Over that period, net income excluding extra items totaled about CN¥41.6b, giving investors a clear read on how headline earnings are translating into underlying profitability and where margins are holding up through the latest quarter. See our full...

Over the last 7 days, the U.S. market has dropped by 2.3%, though it has shown a robust increase of 13% over the past year, with earnings projected to grow by 16% annually in the coming years. In such fluctuating conditions, identifying stocks with strong fundamentals and solid balance sheets can be crucial for investors seeking growth opportunities at lower price points. Penny stocks, often representing smaller or newer companies, continue to present underappreciated potential for growth and...

Over the last 7 days, the United States market has experienced a 2.3% drop, yet it has shown resilience with a 13% rise over the past year and earnings are expected to grow by 16% annually. In such dynamic conditions, dividend stocks can offer investors stability and income potential, making them an attractive option for those seeking steady returns amidst market fluctuations.

We can readily understand why investors are attracted to unprofitable companies. For example, although...

Insiders who bought US$1.73m worth of Cartesian Therapeutics, Inc.'s ( NASDAQ:RNAC ) stock at an average buy price of...

Even if it's not a huge purchase, we think it was good to see that Douglas Reynolds, the President of Energy Services...

We feel now is a pretty good time to analyse CollPlant Biotechnologies Ltd.'s ( NASDAQ:CLGN ) business as it appears...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

On March 10, Centrus Energy (NYSE:LEU) adopted amended bylaws addressing new universal proxy rules. The changes clarify shareholder voting standards and tighten requirements for using universal proxy cards in director elections. The board also updated exclusive forum provisions that govern where certain legal disputes must be brought. Centrus Energy is drawing fresh attention after its board revised the company bylaws to align with evolving proxy and legal frameworks. The move comes as the...

We wouldn't blame Viemed Healthcare, Inc. ( NASDAQ:VMD ) shareholders if they were a little worried about the fact that...

Guangzhou Innogen Pharmaceutical Group (SEHK:2591) has reported its FY 2025 first half with revenue of C¥56.4 million, a basic EPS loss of C¥0.29 and net income loss of C¥122.47 million, while trailing twelve month figures show revenue of C¥131.5 million, a basic EPS loss of C¥0.79 and net income loss of C¥341.36 million. The company has seen first half revenue move from C¥0 in FY 2024 to C¥56.4 million in FY 2025 as EPS moved from a basic loss of C¥0.18 to a loss of C¥0.29. This sets up a...

Best Pacific International Holdings (SEHK:2111) has posted its FY 2025 first half results with revenue of HK$2,329.8 million and basic EPS of HK$0.25, setting the tone against a backdrop of forecast earnings growth of about 18.6% per year and revenue growth of roughly 8.8% per year. The company has seen revenue move from HK$2,385.4 million in 1H 2024 to HK$2,675.9 million in 2H 2024 and then to HK$2,329.8 million in 1H 2025, while EPS has shifted from HK$0.27 to HK$0.32 and now HK$0.25. This...

Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...

The Morning Bull - US Market Morning Update Wednesday, Mar, 25 2026 US stock futures are pointing higher this morning, with key contracts on the S&P 500 and Nasdaq up around 1%, as investors weigh easing tensions in the Middle East against stubbornly high borrowing costs. The US 10 year Treasury yield is sitting above 4.4%, an eight month high, which means mortgages, car loans and business financing remain expensive. At the same time, fresh US business surveys show manufacturing at 52.4 and...

Wondering whether Box at US$23.60 offers good value or if you are better off waiting on the sidelines? This breakdown will help you see how the current price compares with a range of valuation checks. The share price has been mixed recently, with a 3.5% decline over the last week, a 3.2% gain over the last month, and returns of an 18.1% decline year to date and a 23.3% decline over the last year. Recent headlines around Box have focused on its position in content management and collaboration...

WuXi Biologics (Cayman) (SEHK:2269) has reported its FY 2025 numbers with second half revenue of about C¥11.8b and basic EPS of C¥0.64, supported by trailing twelve month revenue of roughly C¥21.8b and EPS of C¥1.22 that sit alongside a 46.3% year over year earnings gain. The company has seen revenue move from around C¥18.7b to C¥21.8b on a trailing basis, while trailing EPS has shifted from C¥0.82 to C¥1.22, setting up a story where rising profit levels are paired with healthier margins that...

As European markets navigate heightened uncertainty stemming from geopolitical tensions and rising energy costs, investors are increasingly focusing on companies with strong fundamentals and insider confidence. In this environment, growth stocks with substantial insider ownership can offer a unique perspective on potential resilience and alignment of interests between management and shareholders.

MIXUE Group (SEHK:2097) FY 2025 earnings snapshot MIXUE Group (SEHK:2097) has reported FY 2025 results with second half revenue of C¥18.7b and basic EPS of C¥2.82, alongside trailing 12 month revenue of C¥33.6b and EPS of C¥7.83, giving investors a fresh look at how the business is scaling. The company has seen revenue move from C¥10.7b and EPS of C¥5.23 in the first half of 2024 to C¥14.9b and EPS of C¥7.23 in the first half of 2025, with trailing 12 month revenue stepping up from C¥24.8b...

Ping An Healthcare and Technology (SEHK:1833) has just posted its FY 2025 first half numbers, with revenue at C¥2.5b and basic EPS of C¥0.07, alongside net income of C¥134.2m that builds on its recent move into profitability. Over the recent reporting periods, revenue has shifted from C¥2.1b in 1H 2024 to C¥2.7b in 2H 2024 and C¥2.5b in 1H 2025, while basic EPS has moved from C¥0.05 in 1H 2024 to C¥0.02 in 2H 2024 and C¥0.07 in 1H 2025. This sets up a results story where investors will be...